Archroma, a global leader in specialty chemicals towards sustainable solutions, today announced that it has appointed Thomas Bucher as its new Chief Financial Officer (CFO) effective 1 October 2021, replacing Roland Waibel who will retire.
GFS Chemicals today introduced a new line of high-purity acids for trace metal analysis across an array of industries, building on its long history in the high-purity acid business.
ARLINGTON, VA – The Society of Chemical Manufacturers and Affiliates (SOCMA) proudly announces two additional dates for its successful Manufacturing Solutions Day platform on September 15 and November 17.
Specialty chemicals company LANXESS completed the second-largest acquisition in its history on August 3 with the takeover of Emerald Kalama Chemical. The US-based specialty chemicals manufacturer was majority-owned by affiliates of private equity firm American Securities LLC. All required regulatory approvals have been received.
Cincinnati, OH - Pilot Chemical Company is taking steps to increase production capacity of its differentiated product lines to allow for future demand increases. To do this, the company is undertaking a multi-phase expansion of its proprietary ice-cold sulfonation technology at its production site in Middletown, Ohio. The entire project is due to be completed by the second half of 2023.
CJB Applied Technologies today announced the opening of its new Bioconversions Lab, a resource highlighting the company’s resolve to invest in assets and capabilities that benefit its customers.
Lonza, a CDMO partner to the biopharma industry, today announced the extension of its collaboration with a major biopharmaceutical partner for the commercial-scale manufacture of monoclonal antibodies, under a long-term agreement.
SOCMA on Thursday called on the Environmental Protection Agency (EPA) to uphold revisions made in 2019 to the Risk Management Plan (RMP) Rulemaking, which has the support of specialty and batch chemical manufacturers.
Lonza announced today the completion of the divestment of its former Specialty Ingredients business and operations to Bain Capital and Cinven for an enterprise value of CHF 4.2 billion.